Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide
Open Access
- 20 April 2007
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 129 (2), 263-275
- https://doi.org/10.1016/j.cell.2007.02.042
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- HIV-1 resistance to the gp41-dependent fusion inhibitor C-34Antiviral Research, 2003
- Analysis of a Primary Isolate-like Virus from Simian and Human Immunodeficiency Virus-Infected Macaque Having Broad Neutralizing ActivityAIDS Research and Human Retroviruses, 2002
- Hemofiltrate CC Chemokine 1[9-74] Causes Effective Internalization of CCR5 and Is a Potent Inhibitor of R5-Tropic Human Immunodeficiency Virus Type 1 Strains in Primary T Cells and MacrophagesAntimicrobial Agents and Chemotherapy, 2002
- Membrane-Perturbing Domains of HIV Type 1 Glycoprotein 41AIDS Research and Human Retroviruses, 2001
- Protein Design of an HIV-1 Entry InhibitorScience, 2001
- Natural Proteolytic Processing of Hemofiltrate Cc Chemokine 1 Generates a Potent Cc Chemokine Receptor (Ccr)1 and Ccr5 Agonist with Anti-HIV PropertiesThe Journal of Experimental Medicine, 2000
- HIV-1 Reverse Transcription A Termination Step at the Center of the GenomeJournal of Molecular Biology, 1994
- The amino-terminal peptide of HIV-1 glycoprotein 41 lyses human erythrocytes and CD4+ lymphocytesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1992
- Solid phase peptide synthesis utilizing 9‐fluorenylmethoxycarbonyl amino acidsInternational Journal of Peptide and Protein Research, 1990
- CD8 + Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus ReplicationScience, 1986